Ad is loading...
ARQT
Price
$10.24
Change
+$0.06 (+0.59%)
Updated
Nov 21 closing price
102 days until earnings call
BEAM
Price
$23.58
Change
-$0.91 (-3.72%)
Updated
Nov 21 closing price
102 days until earnings call
Ad is loading...

ARQT vs BEAM

Header iconARQT vs BEAM Comparison
Open Charts ARQT vs BEAMBanner chart's image
Arcutis Biotherapeutics
Price$10.24
Change+$0.06 (+0.59%)
Volume$1.48M
CapitalizationN/A
Beam Therapeutics
Price$23.58
Change-$0.91 (-3.72%)
Volume$1.01M
CapitalizationN/A
ARQT vs BEAM Comparison Chart
Loading...
ARQT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ARQT vs. BEAM commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARQT is a StrongBuy and BEAM is a StrongBuy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (ARQT: $10.24 vs. BEAM: $23.58)
Brand notoriety: ARQT and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARQT: 66% vs. BEAM: 94%
Market capitalization -- ARQT: $1.2B vs. BEAM: $2.03B
ARQT [@Biotechnology] is valued at $1.2B. BEAM’s [@Biotechnology] market capitalization is $2.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARQT’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • ARQT’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, both ARQT and BEAM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARQT’s TA Score shows that 5 TA indicator(s) are bullish while BEAM’s TA Score has 3 bullish TA indicator(s).

  • ARQT’s TA Score: 5 bullish, 5 bearish.
  • BEAM’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ARQT is a better buy in the short-term than BEAM.

Price Growth

ARQT (@Biotechnology) experienced а +3.12% price change this week, while BEAM (@Biotechnology) price change was -10.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

ARQT is expected to report earnings on Mar 04, 2025.

BEAM is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.03B) has a higher market cap than ARQT($1.2B). ARQT YTD gains are higher at: 217.028 vs. BEAM (-13.373). BEAM (-160.83M) and ARQT (-163.28M) have comparable annual earnings (EBITDA) . BEAM has more cash in the bank: 926M vs. ARQT (331M). BEAM has less debt than ARQT: BEAM (162M) vs ARQT (208M). BEAM has higher revenues than ARQT: BEAM (350M) vs ARQT (139M).
ARQTBEAMARQT / BEAM
Capitalization1.2B2.03B59%
EBITDA-163.28M-160.83M102%
Gain YTD217.028-13.373-1,623%
P/E RatioN/AN/A-
Revenue139M350M40%
Total Cash331M926M36%
Total Debt208M162M128%
TECHNICAL ANALYSIS
Technical Analysis
ARQTBEAM
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
View a ticker or compare two or three
Ad is loading...
ARQT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EATVX44.070.44
+1.01%
Eaton Vance Tx-Mgd Value A
EAFVX22.190.22
+1.00%
Eaton Vance Focused Value Opps A
PRKZX8.080.05
+0.62%
PGIM Real Estate Income Z
MLACX6.400.02
+0.31%
NYLI Winslow Large Cap Growth Class C
PIEIX26.09-0.10
-0.38%
Principal Glb Emerging Markets Inst

ARQT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARQT has been loosely correlated with BEAM. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ARQT jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARQT
1D Price
Change %
ARQT100%
+0.59%
BEAM - ARQT
39%
Loosely correlated
-3.72%
ARWR - ARQT
37%
Loosely correlated
-2.30%
PLRX - ARQT
37%
Loosely correlated
+0.94%
SANA - ARQT
36%
Loosely correlated
-7.11%
RXRX - ARQT
36%
Loosely correlated
-4.80%
More